Australian University Rankings Guide

Research Communications in Molecular Pathology and Pharmacology (ERA Journal)

Research Communications in Molecular Pathology and Pharmacology is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Research Communications in Molecular Pathology and Pharmacology issn is: 1078-0297.

The field covered by Research Communications in Molecular Pathology and Pharmacology as part of the evaluation of Australian university research excellence is:

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Pharmacology and Pharmaceutical Sciences field include:

- ACS Medicinal Chemistry Letters
- BMC Clinical Pharmacology
- Clinical Research and Regulatory Affairs
- Current Pharmaceutical Design
- Drug Development and Industrial Pharmacy
- Drug Metabolism and Personalized Therapy
- Endothelium: Journal of Endothelial Cell Research
- European Journal of Pharmaceutics and Biopharmaceutics
- International Journal of Clinical Pharmacy
- Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Journal of Child and Adolescent Psychopharmacology
- Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
- Journal of Venom Research
- Online Journal of Pharmacokinetics
- Pharmazie in Unserer Zeit


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4